Skip to main content
. 2015 Mar 30;7(6):6538–6551. doi: 10.18632/oncotarget.3731

Figure 2. Recurrently mutated genes identified by whole-exome sequencing and the enriched KEGG pathways for genes altered by copy number gain in GISTs (IM, imatinib mesylate; S, sensitive; R, resistant).

Figure 2